Andrew L. Strong
Founder at K2 Biolabs LLC
Profile
Andrew L.
Strong is the founder of K2 Biolabs LLC.
He is currently a Director at Medicenna Therapeutics, Inc. and a Partner at Pillsbury Winthrop Shaw Pittman LLP.
Previously, he served as President & Chief Executive Officer at FUJIFILM Diosynth Biotechnologies Texas LLC, Independent Non-Executive Director at Braemar Hotels & Resorts, Inc., Independent Non-Executive Director at Medicenna Therapeutics Corp., and Managing Partner at Campbell George & Strong LLP.
He also served as General Counsel & Compliance Officer at The Texas A&M University System.
Mr. Strong received his undergraduate degree from Texas A&M University and his graduate degree from Houston College of Law in 1994.
Andrew L. Strong active positions
Companies | Position | Start |
---|---|---|
Pillsbury Winthrop Shaw Pittman LLP
Pillsbury Winthrop Shaw Pittman LLP Miscellaneous Commercial ServicesCommercial Services Pillsbury Winthrop Shaw Pittman LLP provides legal services. It offers services in education, aviation, communications, consumer and retails, corporate and securities, hospital and intellectual property. The company was founded in 1868 and is headquartered in New York, NY. | Corporate Officer/Principal | 2015-03-24 |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | Director/Board Member | - |
K2 Biolabs LLC
K2 Biolabs LLC Miscellaneous Commercial ServicesCommercial Services K2 Biolabs LLC is an early-stage life science company that aims to develop the next generation of therapies to improve the lives of patients. The company is based in Houston, TX. K2 Biolabs was founded by Kieron Jones, Andrew L. Strong, and Kevin M. Slawin, with Kieron Jones serving as the CEO since incorporation. | Founder | - |
Former positions of Andrew L. Strong
Companies | Position | End |
---|---|---|
MEDICENNA THERAPEUTICS CORP. | Director/Board Member | 2020-09-29 |
BRAEMAR HOTELS & RESORTS INC. | Director/Board Member | 2017-04-30 |
FUJIFILM Diosynth Biotechnologies Texas LLC
FUJIFILM Diosynth Biotechnologies Texas LLC Pharmaceuticals: OtherHealth Technology Fujifilm Diosynth Biotechnology Texas LLC manufactures and distributes biopharmaceutical vaccines. The company was founded on February 25, 2011 and is headquartered in College Station, TX. | Chief Executive Officer | 2015-02-28 |
The Texas A&M University System | Compliance Officer | 2010-12-31 |
Campbell George & Strong LLP | Corporate Officer/Principal | 2004-12-31 |
Training of Andrew L. Strong
Texas A&M University | Undergraduate Degree |
Houston College of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
BRAEMAR HOTELS & RESORTS INC. | Finance |
MEDICENNA THERAPEUTICS CORP. | Health Technology |
Private companies | 6 |
---|---|
FUJIFILM Diosynth Biotechnologies Texas LLC
FUJIFILM Diosynth Biotechnologies Texas LLC Pharmaceuticals: OtherHealth Technology Fujifilm Diosynth Biotechnology Texas LLC manufactures and distributes biopharmaceutical vaccines. The company was founded on February 25, 2011 and is headquartered in College Station, TX. | Health Technology |
Pillsbury Winthrop Shaw Pittman LLP
Pillsbury Winthrop Shaw Pittman LLP Miscellaneous Commercial ServicesCommercial Services Pillsbury Winthrop Shaw Pittman LLP provides legal services. It offers services in education, aviation, communications, consumer and retails, corporate and securities, hospital and intellectual property. The company was founded in 1868 and is headquartered in New York, NY. | Commercial Services |
The Texas A&M University System | Finance |
Campbell George & Strong LLP | |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | Health Technology |
K2 Biolabs LLC
K2 Biolabs LLC Miscellaneous Commercial ServicesCommercial Services K2 Biolabs LLC is an early-stage life science company that aims to develop the next generation of therapies to improve the lives of patients. The company is based in Houston, TX. K2 Biolabs was founded by Kieron Jones, Andrew L. Strong, and Kevin M. Slawin, with Kieron Jones serving as the CEO since incorporation. | Commercial Services |
- Stock Market
- Insiders
- Andrew L. Strong